Detail Information of Transcriptional Regulations
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0171 Transporter Info | ||||
Gene Name | SLC25A13 | ||||
Transporter Name | Calcium-binding mitochondrial carrier protein Aralar2 | ||||
Gene ID | |||||
UniProt ID | |||||
Transcriptional Regulation of This DT (TSR) | ||||||
---|---|---|---|---|---|---|
Class1.1: Basic leucine zipper factors |
Click to Show/Hide the Full List of 5 TF(s) Regulating This DT |
|||||
ATF2 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC25A13 gene | [1] | ||||
TF Protein Name |
Cyclic AMP-dependent transcription factor ATF-2 | Transcription Factor Info | ||||
Tissue |
Blood | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Cyclic AMP-dependent transcription factor ATF-2 (ATF2) can directly bind to the SLC25A13 gene, which in turn affects the expression or function of the drug transporter Calcium-binding mitochondrial carrier protein Aralar2. | |||||
ATF3 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC25A13 gene | [2] | ||||
TF Protein Name |
Cyclic AMP-dependent transcription factor ATF-3 | Transcription Factor Info | ||||
Tissue |
Blood; Bone marrow; Colon; Embryo; Liver | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Cyclic AMP-dependent transcription factor ATF-3 (ATF3) can directly bind to the SLC25A13 gene, which in turn affects the expression or function of the drug transporter Calcium-binding mitochondrial carrier protein Aralar2. | |||||
CEBPB |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC25A13 gene | [3] | ||||
TF Protein Name |
CCAAT/enhancer-binding protein beta | Transcription Factor Info | ||||
Tissue |
Bone | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
CCAAT/enhancer-binding protein beta (CEBPB) can directly bind to the SLC25A13 gene, which in turn affects the expression or function of the drug transporter Calcium-binding mitochondrial carrier protein Aralar2. | |||||
CREB1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC25A13 gene | [1] | ||||
TF Protein Name |
Cyclic AMP-responsive element-binding protein 1 | Transcription Factor Info | ||||
Tissue |
Blood; Liver; Uterus | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Cyclic AMP-responsive element-binding protein 1 (CREB1) can directly bind to the SLC25A13 gene, which in turn affects the expression or function of the drug transporter Calcium-binding mitochondrial carrier protein Aralar2. | |||||
NFE2 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC25A13 gene | [2] | ||||
TF Protein Name |
Transcription factor NF-E2 45 kDa subunit | Transcription Factor Info | ||||
Tissue |
Liver | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcription factor NF-E2 45 kDa subunit (NFE2) can directly bind to the SLC25A13 gene, which in turn affects the expression or function of the drug transporter Calcium-binding mitochondrial carrier protein Aralar2. | |||||
Class1.2: Basic helix-loop-helix factors |
Click to Show/Hide the Full List of 11 TF(s) Regulating This DT |
|||||
ARNTL |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC25A13 gene | [3] | ||||
TF Protein Name |
Basic helix-loop-helix ARNT-like protein 1 | Transcription Factor Info | ||||
Tissue |
Bone; Colon | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Basic helix-loop-helix ARNT-like protein 1 (ARNTL) can directly bind to the SLC25A13 gene, which in turn affects the expression or function of the drug transporter Calcium-binding mitochondrial carrier protein Aralar2. | |||||
ASCL1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC25A13 gene | [4] | ||||
TF Protein Name |
Achaete-scute homolog 1 | Transcription Factor Info | ||||
Tissue |
Lung | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Achaete-scute homolog 1 (ASCL1) can directly bind to the SLC25A13 gene, which in turn affects the expression or function of the drug transporter Calcium-binding mitochondrial carrier protein Aralar2. | |||||
MAX |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC25A13 gene | [4] | ||||
TF Protein Name |
Protein max | Transcription Factor Info | ||||
Tissue |
Blood; Bone marrow; Brain; Breast; Colon; Embryo; Liver; Lung; Vein | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Protein max (MAX) can directly bind to the SLC25A13 gene, which in turn affects the expression or function of the drug transporter Calcium-binding mitochondrial carrier protein Aralar2. | |||||
MITF |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLC25A13 gene in melanoma condition | [5] | ||||
TF Protein Name |
Microphthalmia-associated transcription factor | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Up regulating | |||||
Detailed Description |
Microphthalmia-associated transcription factor (MITF) has been reported to activate the transcription of SLC25A13 gene in melanoma condition, which leads to an increased expression of the drug transporter Calcium-binding mitochondrial carrier protein Aralar2. | |||||
MYOD1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC25A13 gene | [4] | ||||
TF Protein Name |
Myoblast determination protein 1 | Transcription Factor Info | ||||
Tissue |
Myotube | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Myoblast determination protein 1 (MYOD1) can directly bind to the SLC25A13 gene, which in turn affects the expression or function of the drug transporter Calcium-binding mitochondrial carrier protein Aralar2. | |||||
TCF21 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC25A13 gene in coronary artery disease condition | [6] | ||||
TF Protein Name |
Transcription factor 21 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Transcription factor 21 (TCF21) has been reported to bind to the SLC25A13 gene in coronary artery disease condition, which affects the expression or function of the drug transporter Calcium-binding mitochondrial carrier protein Aralar2. | |||||
TCF3 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC25A13 gene | [3] | ||||
TF Protein Name |
Transcription factor E2-alpha | Transcription Factor Info | ||||
Tissue |
Blood | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcription factor E2-alpha (TCF3) can directly bind to the SLC25A13 gene, which in turn affects the expression or function of the drug transporter Calcium-binding mitochondrial carrier protein Aralar2. | |||||
TCF4 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC25A13 gene in glioblastoma multiforme condition | [7] | ||||
TF Protein Name |
Transcription factor 4 | Transcription Factor Info | ||||
Affected Drug/Substrate |
Temozolomide | |||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Transcription factor 4 (TCF4) has been reported to bind to the transcription of SLC25A13 gene in glioblastoma multiforme condition, which leads to an affected expression of the drug transporter Calcium-binding mitochondrial carrier protein Aralar2. | |||||
TFAP4 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC25A13 gene | [1] | ||||
TF Protein Name |
Transcription factor AP-4 | Transcription Factor Info | ||||
Tissue |
Blood | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcription factor AP-4 (TFAP4) can directly bind to the SLC25A13 gene, which in turn affects the expression or function of the drug transporter Calcium-binding mitochondrial carrier protein Aralar2. | |||||
USF1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLC25A13 gene in hepatoblastoma condition | [8] | ||||
TF Protein Name |
Upstream stimulatory factor 1 | Transcription Factor Info | ||||
Studied Phenotype |
Hepatoblastoma [ICD11: 2C12.01] | |||||
Tissue |
Liver | |||||
Related DT Changes |
Up regulating | |||||
Experimental Material |
Human hepatoblastoma cells (HepG2) | |||||
Detailed Description |
Upstream stimulatory factor 1 (USF1) has been reported to activate the transcription of SLC25A13 gene in hepatoblastoma condition, which leads to an increased expression of the drug transporter Calcium-binding mitochondrial carrier protein Aralar2. | |||||
USF2 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC25A13 gene | [2] | ||||
TF Protein Name |
Upstream stimulatory factor 2 | Transcription Factor Info | ||||
Tissue |
Blood; Bone marrow; Cervix; Embryo; Liver | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Upstream stimulatory factor 2 (USF2) can directly bind to the SLC25A13 gene, which in turn affects the expression or function of the drug transporter Calcium-binding mitochondrial carrier protein Aralar2. | |||||
Class2.1: Nuclear receptors with C4 zinc fingers |
Click to Show/Hide the Full List of 5 TF(s) Regulating This DT |
|||||
AR |
Click to Show/Hide to Show 3 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC25A13 gene in prostate cancer condition | [9] | ||||
TF Protein Name |
Androgen receptor | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Androgen receptor (AR) has been reported to bind to the transcription of SLC25A13 gene in prostate cancer condition, which leads to a affected expression of the drug transporter Calcium-binding mitochondrial carrier protein Aralar2. | |||||
Transcriptional Phenomenon2 |
Binding to SLC25A13 gene | [10] | ||||
TF Protein Name |
Androgen receptor | Transcription Factor Info | ||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Androgen receptor (AR) has been reported to bind to the transcription of SLC25A13 gene in . condition, which leads to a affected expression of the drug transporter Calcium-binding mitochondrial carrier protein Aralar2. | |||||
Transcriptional Phenomenon3 |
Binding to SLC25A13 gene in prostate cancer condition | [11] | ||||
TF Protein Name |
Androgen receptor | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Androgen receptor (AR) has been reported to bind to the transcription of SLC25A13 gene in prostate cancer condition, which leads to an affected expression of the drug transporter Calcium-binding mitochondrial carrier protein Aralar2. | |||||
HNF4A |
Click to Show/Hide to Show 2 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC25A13 gene in health condition | [12] | ||||
TF Protein Name |
Hepatocyte nuclear factor 4-alpha | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Hepatocyte nuclear factor 4-alpha (HNF4A) has been reported to bind to the transcription of SLC25A13 gene in health condition, which leads to an affected expression of the drug transporter Calcium-binding mitochondrial carrier protein Aralar2. | |||||
Transcriptional Phenomenon2 |
Direct binding to SLC25A13 gene | [4] | ||||
TF Protein Name |
Hepatocyte nuclear factor 4-alpha | Transcription Factor Info | ||||
Tissue |
Intestine; Liver | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Hepatocyte nuclear factor 4-alpha (HNF4A) can directly bind to the SLC25A13 gene, which in turn affects the expression or function of the drug transporter Calcium-binding mitochondrial carrier protein Aralar2. | |||||
HNF4G |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC25A13 gene | [2] | ||||
TF Protein Name |
Hepatocyte nuclear factor 4-gamma | Transcription Factor Info | ||||
Tissue |
Liver | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Hepatocyte nuclear factor 4-gamma (HNF4G) can directly bind to the SLC25A13 gene, which in turn affects the expression or function of the drug transporter Calcium-binding mitochondrial carrier protein Aralar2. | |||||
NR2F2 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC25A13 gene | [1] | ||||
TF Protein Name |
COUP transcription factor 2 | Transcription Factor Info | ||||
Tissue |
Bone marrow; Breast; Liver | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
COUP transcription factor 2 (NR2F2) can directly bind to the SLC25A13 gene, which in turn affects the expression or function of the drug transporter Calcium-binding mitochondrial carrier protein Aralar2. | |||||
VDR |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC25A13 gene in THP-1 human monocytic leukemia cells condition | [13] | ||||
TF Protein Name |
Vitamin D3 receptor | Transcription Factor Info | ||||
Affected Drug/Substrate |
1,25-dihydroxyvitamin D3 | |||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Vitamin D3 receptor (VDR) has been reported to bind to the transcription of SLC25A13 gene in THP-1 human monocytic leukemia cells condition, which leads to an affected expression of the drug transporter Calcium-binding mitochondrial carrier protein Aralar2. | |||||
Class2.2: Other C4 zinc finger-type factors |
Click to Show/Hide the Full List of 3 TF(s) Regulating This DT |
|||||
GATA1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC25A13 gene | [3] | ||||
TF Protein Name |
Erythroid transcription factor | Transcription Factor Info | ||||
Tissue |
Blood; Bone marrow | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Erythroid transcription factor (GATA1) can directly bind to the SLC25A13 gene, which in turn affects the expression or function of the drug transporter Calcium-binding mitochondrial carrier protein Aralar2. | |||||
GATA3 |
Click to Show/Hide to Show 2 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC25A13 gene in breast cancer condition | [14] | ||||
TF Protein Name |
Trans-acting T-cell-specific transcription factor GATA-3 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Trans-acting T-cell-specific transcription factor GATA-3 (GATA3) has been reported to bind to the transcription of SLC25A13 gene in breast cancer condition, which leads to an affected expression of the drug transporter Calcium-binding mitochondrial carrier protein Aralar2. | |||||
Transcriptional Phenomenon2 |
Direct binding to SLC25A13 gene | [1] | ||||
TF Protein Name |
Trans-acting T-cell-specific transcription factor GATA-3 | Transcription Factor Info | ||||
Tissue |
Blood; Breast | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Trans-acting T-cell-specific transcription factor GATA-3 (GATA3) can directly bind to the SLC25A13 gene, which in turn affects the expression or function of the drug transporter Calcium-binding mitochondrial carrier protein Aralar2. | |||||
GATA4 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC25A13 gene in gastric cancer condition | [15] | ||||
TF Protein Name |
Transcription factor GATA-4 | Transcription Factor Info | ||||
Affected Drug/Substrate |
metformin | |||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Transcription factor GATA-4 (GATA4) has been reported to bind to the transcription of SLC25A13 gene in gastric cancer condition, which leads to an affected expression of the drug transporter Calcium-binding mitochondrial carrier protein Aralar2. | |||||
Class2.3: C2H2 zinc finger factors |
Click to Show/Hide the Full List of 7 TF(s) Regulating This DT |
|||||
BCL11A |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC25A13 gene | [1] | ||||
TF Protein Name |
B-cell lymphoma/leukemia 11A | Transcription Factor Info | ||||
Tissue |
Blood | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
B-cell lymphoma/leukemia 11A (BCL11A) can directly bind to the SLC25A13 gene, which in turn affects the expression or function of the drug transporter Calcium-binding mitochondrial carrier protein Aralar2. | |||||
EGR1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC25A13 gene in erythroleukemia condition | [16] | ||||
TF Protein Name |
Early growth response protein 1 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Early growth response protein 1 (EGR1) has been reported to bind to the transcription of SLC25A13 gene in erythroleukemia condition, which leads to an affected expression of the drug transporter Calcium-binding mitochondrial carrier protein Aralar2. | |||||
GLIS1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC25A13 gene | [4] | ||||
TF Protein Name |
Zinc finger protein GLIS1 | Transcription Factor Info | ||||
Tissue |
Blood; Colon | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Zinc finger protein GLIS1 (GLIS1) can directly bind to the SLC25A13 gene, which in turn affects the expression or function of the drug transporter Calcium-binding mitochondrial carrier protein Aralar2. | |||||
KLF4 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC25A13 gene | [2] | ||||
TF Protein Name |
Krueppel-like factor 4 | Transcription Factor Info | ||||
Tissue |
Foreskin; Pancreatic ductal; Skin | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Krueppel-like factor 4 (KLF4) can directly bind to the SLC25A13 gene, which in turn affects the expression or function of the drug transporter Calcium-binding mitochondrial carrier protein Aralar2. | |||||
KLF5 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC25A13 gene | [3] | ||||
TF Protein Name |
Krueppel-like factor 5 | Transcription Factor Info | ||||
Tissue |
Colon; Pancreatic ductal; Stomach | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Krueppel-like factor 5 (KLF5) can directly bind to the SLC25A13 gene, which in turn affects the expression or function of the drug transporter Calcium-binding mitochondrial carrier protein Aralar2. | |||||
MAZ |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC25A13 gene | [3] | ||||
TF Protein Name |
Myc-associated zinc finger protein | Transcription Factor Info | ||||
Tissue |
Blood; Bone marrow; Cervix; Liver; Lung | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Myc-associated zinc finger protein (MAZ) can directly bind to the SLC25A13 gene, which in turn affects the expression or function of the drug transporter Calcium-binding mitochondrial carrier protein Aralar2. | |||||
ZNF263 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC25A13 gene | [4] | ||||
TF Protein Name |
Zinc finger protein 263 | Transcription Factor Info | ||||
Tissue |
Bone marrow; Kidney | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Zinc finger protein 263 (ZNF263) can directly bind to the SLC25A13 gene, which in turn affects the expression or function of the drug transporter Calcium-binding mitochondrial carrier protein Aralar2. | |||||
Class3.1: Homeo domain factors |
Click to Show/Hide the Full List of 2 TF(s) Regulating This DT |
|||||
CUX1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLC25A13 gene in multiple human cancer types condition | [17] | ||||
TF Protein Name |
Homeobox protein cut-like 1 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Up regulating | |||||
Detailed Description |
Homeobox protein cut-like 1 (CUX1) has been reported to activate the transcription of SLC25A13 gene in multiple human cancer types condition, which leads to an increased expression of the drug transporter Calcium-binding mitochondrial carrier protein Aralar2. | |||||
POU2F2 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC25A13 gene | [1] | ||||
TF Protein Name |
POU domain, class 2, transcription factor 2 | Transcription Factor Info | ||||
Tissue |
Blood | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
POU domain, class 2, transcription factor 2 (POU2F2) can directly bind to the SLC25A13 gene, which in turn affects the expression or function of the drug transporter Calcium-binding mitochondrial carrier protein Aralar2. | |||||
Class3.3: Fork head / winged helix factors |
Click to Show/Hide the Full List of 5 TF(s) Regulating This DT |
|||||
FOXA1 |
Click to Show/Hide to Show 2 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC25A13 gene in prostate cancer condition | [18] | ||||
TF Protein Name |
Hepatocyte nuclear factor 3-alpha | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Hepatocyte nuclear factor 3-alpha (FOXA1) has been reported to bind to the transcription of SLC25A13 gene in prostate cancer condition, which leads to an affected expression of the drug transporter Calcium-binding mitochondrial carrier protein Aralar2. | |||||
Transcriptional Phenomenon2 |
Direct binding to SLC25A13 gene | [1] | ||||
TF Protein Name |
Hepatocyte nuclear factor 3-alpha | Transcription Factor Info | ||||
Tissue |
Breast; Embryo; Liver; Lung; Pancreatic ductal; Prostate | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Hepatocyte nuclear factor 3-alpha (FOXA1) can directly bind to the SLC25A13 gene, which in turn affects the expression or function of the drug transporter Calcium-binding mitochondrial carrier protein Aralar2. | |||||
FOXA2 |
Click to Show/Hide to Show 2 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC25A13 gene in health condition | [12] | ||||
TF Protein Name |
Hepatocyte nuclear factor 3-beta | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Hepatocyte nuclear factor 3-beta (FOXA2) has been reported to bind to the transcription of SLC25A13 gene in health condition, which leads to an affected expression of the drug transporter Calcium-binding mitochondrial carrier protein Aralar2. | |||||
Transcriptional Phenomenon2 |
Activation of SLC25A13 gene in hepatoblastoma condition | [8] | ||||
TF Protein Name |
Hepatocyte nuclear factor 3-beta | Transcription Factor Info | ||||
Studied Phenotype |
Hepatoblastoma [ICD11: 2C12.01] | |||||
Tissue |
Liver | |||||
Related DT Changes |
Up regulating | |||||
Experimental Material |
Human hepatoblastoma cells (HepG2) | |||||
Detailed Description |
Hepatocyte nuclear factor 3-beta (FOXA2) has been reported to activate the transcription of SLC25A13 gene in hepatoblastoma condition, which leads to an increased expression of the drug transporter Calcium-binding mitochondrial carrier protein Aralar2. | |||||
FOXM1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLC25A13 gene in breast cancer condition | [19] | ||||
TF Protein Name |
Forkhead box protein M1 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Up regulating | |||||
Detailed Description |
Forkhead box protein M1 (FOXM1) has been reported to activate the transcription of SLC25A13 gene in breast cancer condition, which leads to an increased expression of the drug transporter Calcium-binding mitochondrial carrier protein Aralar2. | |||||
FOXO3 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLC25A13 gene in tumorigenesis condition | [20] | ||||
TF Protein Name |
Forkhead box protein O3 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Up regulating | |||||
Detailed Description |
Forkhead box protein O3 (FOXO3) has been reported to activate the transcription of SLC25A13 gene in tumorigenesis condition, which leads to an increased expression of the drug transporter Calcium-binding mitochondrial carrier protein Aralar2. | |||||
FOXP1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC25A13 gene | [1] | ||||
TF Protein Name |
Forkhead box protein P1 | Transcription Factor Info | ||||
Tissue |
Blood; Prostate | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Forkhead box protein P1 (FOXP1) can directly bind to the SLC25A13 gene, which in turn affects the expression or function of the drug transporter Calcium-binding mitochondrial carrier protein Aralar2. | |||||
Class3.5: Tryptophan cluster factors |
Click to Show/Hide the Full List of 8 TF(s) Regulating This DT |
|||||
ERG |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC25A13 gene | [2] | ||||
TF Protein Name |
Transcriptional regulator ERG | Transcription Factor Info | ||||
Tissue |
Aorta | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcriptional regulator ERG (ERG) can directly bind to the SLC25A13 gene, which in turn affects the expression or function of the drug transporter Calcium-binding mitochondrial carrier protein Aralar2. | |||||
ETS1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC25A13 gene | [3] | ||||
TF Protein Name |
Protein C-ets-1 | Transcription Factor Info | ||||
Tissue |
Blood; Bone; Bone marrow; Kidney; Lung; Prostate; Vein | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Protein C-ets-1 (ETS1) can directly bind to the SLC25A13 gene, which in turn affects the expression or function of the drug transporter Calcium-binding mitochondrial carrier protein Aralar2. | |||||
ETS2 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC25A13 gene | [2] | ||||
TF Protein Name |
Protein C-ets-2 | Transcription Factor Info | ||||
Tissue |
Colon | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Protein C-ets-2 (ETS2) can directly bind to the SLC25A13 gene, which in turn affects the expression or function of the drug transporter Calcium-binding mitochondrial carrier protein Aralar2. | |||||
FLI1 |
Click to Show/Hide to Show 2 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC25A13 gene in megakaryocytes condition | [21] | ||||
TF Protein Name |
Friend leukemia integration 1 transcription factor | Transcription Factor Info | ||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Friend leukemia integration 1 transcription factor (FLI1) has been reported to bind to the transcription of SLC25A13 gene in megakaryocytes condition, which leads to an affected expression of the drug transporter Calcium-binding mitochondrial carrier protein Aralar2. | |||||
Transcriptional Phenomenon2 |
Direct binding to SLC25A13 gene | [3] | ||||
TF Protein Name |
Friend leukemia integration 1 transcription factor | Transcription Factor Info | ||||
Tissue |
Blood; Mesenchymal; Vein | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Friend leukemia integration 1 transcription factor (FLI1) can directly bind to the SLC25A13 gene, which in turn affects the expression or function of the drug transporter Calcium-binding mitochondrial carrier protein Aralar2. | |||||
GABPA |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC25A13 gene | [4] | ||||
TF Protein Name |
GA-binding protein alpha chain | Transcription Factor Info | ||||
Tissue |
Brain; Embryo; Liver; Mesenchymal; Prostate | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
GA-binding protein alpha chain (GABPA) can directly bind to the SLC25A13 gene, which in turn affects the expression or function of the drug transporter Calcium-binding mitochondrial carrier protein Aralar2. | |||||
IRF4 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC25A13 gene | [2] | ||||
TF Protein Name |
Interferon regulatory factor 4 | Transcription Factor Info | ||||
Tissue |
Blood | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Interferon regulatory factor 4 (IRF4) can directly bind to the SLC25A13 gene, which in turn affects the expression or function of the drug transporter Calcium-binding mitochondrial carrier protein Aralar2. | |||||
MYBL2 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC25A13 gene | [3] | ||||
TF Protein Name |
Myb-related protein B | Transcription Factor Info | ||||
Tissue |
Colon; Liver | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Myb-related protein B (MYBL2) can directly bind to the SLC25A13 gene, which in turn affects the expression or function of the drug transporter Calcium-binding mitochondrial carrier protein Aralar2. | |||||
SPI1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC25A13 gene in K562 cells | [22] | ||||
TF Protein Name |
Transcription factor PU.1 | Transcription Factor Info | ||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Transcription factor PU.1 (SPI1) has been reported to bind to the transcription of SLC25A13 gene in K562 cells, which leads to an affected expression of the drug transporter Calcium-binding mitochondrial carrier protein Aralar2. | |||||
Class3.7: ARID domain factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
ARID3A |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC25A13 gene | [4] | ||||
TF Protein Name |
AT-rich interactive domain-containing protein 3A | Transcription Factor Info | ||||
Tissue |
Liver | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
AT-rich interactive domain-containing protein 3A (ARID3A) can directly bind to the SLC25A13 gene, which in turn affects the expression or function of the drug transporter Calcium-binding mitochondrial carrier protein Aralar2. | |||||
Class4.2: Heteromeric CCAAT-binding factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
NFYB |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC25A13 gene | [4] | ||||
TF Protein Name |
Nuclear transcription factor Y subunit beta | Transcription Factor Info | ||||
Tissue |
Bone marrow | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Nuclear transcription factor Y subunit beta (NFYB) can directly bind to the SLC25A13 gene, which in turn affects the expression or function of the drug transporter Calcium-binding mitochondrial carrier protein Aralar2. | |||||
Class6.1: Rel homology region factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
NFATC1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC25A13 gene | [3] | ||||
TF Protein Name |
Nuclear factor of activated T-cells, cytoplasmic 1 | Transcription Factor Info | ||||
Tissue |
Blood | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Nuclear factor of activated T-cells, cytoplasmic 1 (NFATC1) can directly bind to the SLC25A13 gene, which in turn affects the expression or function of the drug transporter Calcium-binding mitochondrial carrier protein Aralar2. | |||||
Class6.2: STAT domain factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
STAT5A |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC25A13 gene | [4] | ||||
TF Protein Name |
Signal transducer and activator of transcription 5A | Transcription Factor Info | ||||
Tissue |
Blood | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Signal transducer and activator of transcription 5A (STAT5A) can directly bind to the SLC25A13 gene, which in turn affects the expression or function of the drug transporter Calcium-binding mitochondrial carrier protein Aralar2. | |||||
Class6.3: p53 domain factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
TP63 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC25A13 gene in epithelial to mesenchymal transition condition | [23] | ||||
TF Protein Name |
Tumor protein 63 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Tumor protein 63 (TP63) has been reported to bind to the transcription of SLC25A13 gene in epithelial to mesenchymal transition condition, which leads to an affected expression of the drug transporter Calcium-binding mitochondrial carrier protein Aralar2. | |||||
Class6.4: Runt domain factors |
Click to Show/Hide the Full List of 2 TF(s) Regulating This DT |
|||||
RUNX2 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLC25A13 gene in prostate cancer condition | [24] | ||||
TF Protein Name |
Runt-related transcription factor 2 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Up regulating | |||||
Detailed Description |
Runt-related transcription factor 2 (RUNX2) has been reported to activate the transcription of SLC25A13 gene in prostate cancer condition, which leads to an increased expression of the drug transporter Calcium-binding mitochondrial carrier protein Aralar2. | |||||
RUNX3 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC25A13 gene | [1] | ||||
TF Protein Name |
Runt-related transcription factor 3 | Transcription Factor Info | ||||
Tissue |
Blood | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Runt-related transcription factor 3 (RUNX3) can directly bind to the SLC25A13 gene, which in turn affects the expression or function of the drug transporter Calcium-binding mitochondrial carrier protein Aralar2. | |||||
Class6.7: Grainyhead domain factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
GRHL2 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC25A13 gene | [2] | ||||
TF Protein Name |
Grainyhead-like protein 2 homolog | Transcription Factor Info | ||||
Tissue |
Breast; Bronchus; Ovary | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Grainyhead-like protein 2 homolog (GRHL2) can directly bind to the SLC25A13 gene, which in turn affects the expression or function of the drug transporter Calcium-binding mitochondrial carrier protein Aralar2. | |||||
TF Superclass7: beta-Hairpin exposed by an alpha/beta-scaffold |
||||||
Class7.1: SMAD/NF-1 DNA-binding domain factors |
Click to Show/Hide the Full List of 3 TF(s) Regulating This DT |
|||||
NFIC |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC25A13 gene | [4] | ||||
TF Protein Name |
Nuclear factor 1 C-type | Transcription Factor Info | ||||
Tissue |
Blood; Brain; Liver; Uterus | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Nuclear factor 1 C-type (NFIC) can directly bind to the SLC25A13 gene, which in turn affects the expression or function of the drug transporter Calcium-binding mitochondrial carrier protein Aralar2. | |||||
SMAD3 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLC25A13 gene in health condition | [25] | ||||
TF Protein Name |
Mothers against decapentaplegic homolog 3 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Up regulating | |||||
Detailed Description |
Mothers against decapentaplegic homolog 3 (SMAD3) has been reported to activate the transcription of SLC25A13 gene in health condition, which leads to an increased expression of the drug transporter Calcium-binding mitochondrial carrier protein Aralar2. | |||||
SMAD4 |
Click to Show/Hide to Show 2 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC25A13 gene in epithelial ovarian cancer condition | [26] | ||||
TF Protein Name |
Mothers against decapentaplegic homolog 4 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Mothers against decapentaplegic homolog 4 (SMAD4) has been reported to bind to the transcription of SLC25A13 gene in epithelial ovarian cancer condition, which leads to an affected expression of the drug transporter Calcium-binding mitochondrial carrier protein Aralar2. | |||||
Transcriptional Phenomenon2 |
Activation of SLC25A13 gene in hESCs | [25] | ||||
TF Protein Name |
Mothers against decapentaplegic homolog 4 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Up regulating | |||||
Detailed Description |
Mothers against decapentaplegic homolog 4 (SMAD4) has been reported to activate the transcription of SLC25A13 gene in human embryonic stem cells (hESCs), which leads to an increased expression of the drug transporter Calcium-binding mitochondrial carrier protein Aralar2. | |||||
Class10.1: Other factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
ZBTB10 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC25A13 gene | [2] | ||||
TF Protein Name |
Zinc finger and BTB domain-containing protein 10 | Transcription Factor Info | ||||
Tissue |
Colon | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Zinc finger and BTB domain-containing protein 10 (ZBTB10) can directly bind to the SLC25A13 gene, which in turn affects the expression or function of the drug transporter Calcium-binding mitochondrial carrier protein Aralar2. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Li and Dr. Fu.